DAVID WANGERIN LILE: Open Payments
NPI 1639263775 · WAYNESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$540 in 18 payments from 8 companies in 2025. Trend: 2023 $1,170 · 2024 $270 · 2025 $540
Food & beverage: $540
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 5 | $225 |
| Novo Nordisk Inc | 3 | $96 |
| ABBVIE INC. | 3 | $65 |
| Axsome Therapeutics, Inc. | 2 | $51 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
| Stryker Corporation | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Amgen Inc. | 1 | $21 |
Products named: FANAPT, VRAYLAR, Ozempic, Auvelity, Wegovy, UZEDY, CLOTTRIEVER BOLD CATHETER, COBENFY.
Industry payments across NC — which companies pay providers there.
